P. Claudepierre, D. Wendling, M. Breban, P. Goupillle, and M. Dougados, Ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, or spondylarthritis: What's in a name? Joint Bone Spine

A. Saraux, F. Guillemin, P. Guggenbuhl, C. Roux, P. Fardellone et al., Prevalence of spondyloarthropathies in France: 2001, Prevalence of spondyloarthropathies in France, pp.1431-1436, 2001.
DOI : 10.1136/ard.2004.029207

S. Van-der-linden, H. Valkenburg, and A. Cats, Evaluation of Diagnostic Criteria for Ankylosing Spondylitis, Arthritis & Rheumatism, vol.2, issue.4, pp.361-369, 1984.
DOI : 10.1002/art.1780270401

M. Dougados, S. Van-der-linden, R. Juhlin, B. Huitfeldt, B. Amor et al., The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy, Arthritis & Rheumatism, vol.57, issue.10, pp.1218-1245, 1991.
DOI : 10.1002/art.1780341003

W. Mau, H. Zeidler, R. Mau, A. Majewski, J. Freyschmidt et al., Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup, J Rheumatol, vol.15, pp.1109-1123, 1988.

B. Amor, M. Dougados, and M. Mijiyawa, Criteria of the classification of spondylarthropathies, Rev Rhum Mal Osteoartic, vol.57, pp.85-94, 1990.

A. Calin, J. Porta, and J. Fries, Clinical History as a Screening Test for Ankylosing Spondylitis, JAMA: The Journal of the American Medical Association, vol.237, issue.24, pp.2613-2617, 1977.
DOI : 10.1001/jama.1977.03270510035017

A. Bennett, D. Mcgonagle, O. Connor, P. Hensor, E. Sivera et al., Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years, Arthritis & Rheumatism, vol.10, issue.11, pp.3413-3421, 2008.
DOI : 10.1002/art.24024

M. Rudwaleit, H. Haibel, X. Baraliakos, J. Listing, E. Märker-hermann et al., The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort, Arthritis & Rheumatism, vol.33, issue.3, pp.717-744, 2009.
DOI : 10.1002/art.24483

H. Haibel, M. Rudwaleit, J. Listing, F. Heldmann, R. Wong et al., Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve???week randomized, double???blind, placebo???controlled trial followed by an open???label extension up to week fifty???two, Arthritis & Rheumatism, vol.58, issue.7, pp.1981-91, 2008.
DOI : 10.1002/art.23606

M. Rudwaleit, D. Van-der-heijde, M. Khan, J. Braun, and J. Sieper, How to diagnose axial spondyloarthritis early, Annals of the Rheumatic Diseases, vol.63, issue.5, pp.535-578, 2004.
DOI : 10.1136/ard.2003.011247

M. Rudwaleit, M. Khan, and J. Sieper, The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?, Arthritis & Rheumatism, vol.67, issue.4, pp.1000-1008, 2005.
DOI : 10.1002/art.20990

M. Rudwaleit, A. Jurik, K. Hermann, R. Landewé, D. Van-der-heijde et al., Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group, Annals of the Rheumatic Diseases, vol.68, issue.10, pp.1520-1527, 2009.
DOI : 10.1136/ard.2009.110767

M. Rudwaleit, D. Van-der-heijde, R. Landewé, J. Listing, N. Akkoc et al., The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection, Annals of the Rheumatic Diseases, vol.68, issue.6, pp.777-83, 2009.
DOI : 10.1136/ard.2009.108233

P. Cheung, S. Paternotte, V. Burki, A. Durnez, M. Elhai et al., Performance of the Assessment in Spondyloarthritis International Society Classification for Axial and Peripheral Spondyloarthritis in an Established Clinical Cohort: Comparison with Criteria Sets of Amor and the European Spondylarthropathy Study Group, The Journal of Rheumatology, vol.39, issue.4, pp.816-837
DOI : 10.3899/jrheum.111088

J. Braun, R. Van-den-berg, X. Baraliakos, H. Boehm, R. Burgos-vargas et al., 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.896-904, 2011.
DOI : 10.1136/ard.2011.151027

S. Garrett, T. Jenkinson, L. Kennedy, H. Whitelock, P. Gaisford et al., A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index, J Rheumatol, vol.21, pp.2286-91, 1994.

A. Spoorenberg, A. Van-tubergen, R. Landewé, M. Dougados, S. Van-der-linden et al., Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives, Rheumatology, vol.44, issue.6, pp.789-95, 2005.
DOI : 10.1093/rheumatology/keh595

L. Heuft-dorenbosch, A. Van-tubergen, and A. Spoorenberg, The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index, Arthritis Care & Research, vol.24, issue.2, pp.154-159, 2004.
DOI : 10.1002/art.20233

I. Song, M. Rudwaleit, and J. Listing, Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations, Annals of the Rheumatic Diseases, vol.68, issue.11, pp.1701-1707, 2009.
DOI : 10.1136/ard.2008.099226

C. Lukas, R. Landewé, J. Sieper, M. Dougados, J. Davis et al., Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.18-24, 2009.
DOI : 10.1136/ard.2008.094870

P. Machado, R. Landewe, and E. Lie, Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores, Annals of the Rheumatic Diseases, vol.70, issue.1, pp.47-53, 2011.
DOI : 10.1136/ard.2010.138594

S. Neveu, Y. Degboé, D. Cornec, T. Pham, D. Wendling et al., Comment definir l'activité d'une spondylarthrite ? Revue du Rhumatisme, pp.215-239

D. Van-der-heijde, E. Lie, T. Kvien, J. Sieper, F. Van-den-bosch et al., ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.68, issue.12, pp.1811-1819, 2009.
DOI : 10.1136/ard.2008.100826

P. Machado and D. Van-der-heijde, How to measure disease activity in axial spondyloarthritis?, Current Opinion in Rheumatology, vol.23, issue.4, pp.339-384, 2011.
DOI : 10.1097/BOR.0b013e3283470f23

D. Der-heijde, J. Sieper, W. Maksymowych, M. Dougados, R. Burgos-vargas et al., 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.905-913, 2011.
DOI : 10.1136/ard.2011.151563

K. Fagerli, E. Lie, D. Van-der-heijde, M. Heiberg, C. Kaufmann et al., Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria, Rheumatology, vol.51, issue.8, pp.1479-83, 2012.
DOI : 10.1093/rheumatology/kes057

J. Anderson, G. Baron, D. Van-der-heijde, D. Felson, and M. Dougados, Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis, Arthritis & Rheumatism, vol.26, issue.8, pp.1876-86, 2001.
DOI : 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F

A. Van-tubergen, D. Van-der-heijde, J. Anderson, R. Landewe, M. Dougados et al., Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel, Annals of the Rheumatic Diseases, vol.62, issue.3, pp.215-236, 2003.
DOI : 10.1136/ard.62.3.215

J. Brandt, J. Listing, J. Sieper, M. Rudwaleit, D. Van-der-heijde et al., Development and preselection of criteria for short term improvement after anti-TNF?? treatment in ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.63, issue.11, pp.1438-1482, 2004.
DOI : 10.1136/ard.2003.016717

A. Spoorenberg, D. Van-der-heijde, E. De-klerk, M. Dougados, K. De-vlam et al., Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis, J Rheumatol, vol.26, pp.980-984, 1999.

M. Dougados, A. Gueguen, and J. Nakache, Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis, J Rheumatol, vol.26, pp.971-975, 1999.

J. Ruof and G. Stucki, Validity aspects of erythrocyte sedimentation rate and C reactive protein in ankylosing spondylitis: a literature review, J Rheumatol, vol.26, pp.966-70, 1999.

M. Dougados, M. Agostino, J. Benessiano, F. Berenbaum, M. Breban et al., The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patients, Joint Bone Spine, vol.78, issue.6, pp.598-603, 2011.
DOI : 10.1016/j.jbspin.2011.01.013

URL : https://hal.archives-ouvertes.fr/hal-00730858

T. Pham, R. Landewé, S. Van-der-linden, M. Dougados, J. Sieper et al., An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.65, issue.12, pp.1620-1625, 2006.
DOI : 10.1136/ard.2005.042630

M. Benhamou, L. Gossec, and M. Dougados, Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein, Rheumatology, vol.49, issue.3, pp.536-577, 2010.
DOI : 10.1093/rheumatology/kep393

T. Kvien, H. Lie, and E. , A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases, Clin Exp Rheumatol, vol.23, pp.188-94, 2005.

M. De-vries, I. Van-eijk, I. Van-der-horst-bruinsma, M. Peters, M. Nurmohamed et al., Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis, Arthritis Care & Research, vol.2, issue.11, pp.1484-90, 2009.
DOI : 10.1002/art.24838

D. Poddubnyy, M. Rudwaleit, J. Listing, J. Braun, and J. Sieper, Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis, Annals of the Rheumatic Diseases, vol.69, issue.7, pp.1338-1379, 2010.
DOI : 10.1136/ard.2009.120139

B. Glintborg, M. Ostergaard, and N. Krogh, Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry, Annals of the Rheumatic Diseases, vol.69, issue.11, pp.2002-2010, 2010.
DOI : 10.1136/ard.2009.124446

S. Arends, E. Brouwer, and E. Van-der-veer, Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study, Arthritis Research & Therapy, vol.13, issue.3, p.94, 2011.
DOI : 10.1136/ard.2008.089979

M. Rudwaleit, J. Listing, J. Brandt, J. Braun, and J. Sieper, Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor ?? blockers in ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.63, issue.6, pp.665-70, 2004.
DOI : 10.1136/ard.2003.016386

D. Van-der-heijde, A. Kivitz, M. Schiff, J. Sieper, B. Dijkmans et al., Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.62, issue.7, p.213646, 2006.
DOI : 10.1002/art.21913

D. Van-der-heijde, B. Dijkmans, P. Geusens, J. Sieper, K. Dewoody et al., Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT), Arthritis & Rheumatism, vol.50, issue.2, pp.582-91, 2005.
DOI : 10.1002/art.20852

J. Davis, . Jr, D. Van-der-heijde, J. Braun, M. Dougados et al., Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial, Arthritis & Rheumatism, vol.44, issue.11, pp.3230-3236, 2003.
DOI : 10.1002/art.11325

E. Collantes, P. Zarco, E. Muñoz, X. Juanola, J. Mulero et al., Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report, Rheumatology, vol.46, issue.8, pp.1309-1324, 2007.
DOI : 10.1093/rheumatology/kem084

J. Sieper, D. Van-der-heijde, M. Dougados, P. Mease, W. Maksymowych et al., Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1), Annals of the Rheumatic Diseases, vol.72, issue.6, p.22772328, 2012.
DOI : 10.1136/annrheumdis-2012-201766

S. Pedersen, I. Sørensen, K. Hermann, O. Madsen, N. Tvede et al., Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor ?? inhibitors, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.1065-71, 2010.
DOI : 10.1136/ard.2009.111187

M. Xu, Z. Lin, X. Deng, L. Li, Y. Wei et al., The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-?? inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China, Rheumatology, vol.50, issue.8, pp.1466-72, 2011.
DOI : 10.1093/rheumatology/ker087

D. Van-der-heijde, J. Braun, M. Dougados, J. Sieper, R. Pedersen et al., Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial, Rheumatology, vol.51, issue.10, pp.1894-90522772319, 2012.
DOI : 10.1093/rheumatology/kes142

J. Braun, R. Van-den-berg, X. Baraliakos, H. Boehm, R. Burgos-vargas et al., 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.896-904, 2011.
DOI : 10.1136/ard.2011.151027

K. Nas, K. Yildirim, R. Cevik, S. Karatay, A. Erdal et al., Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis, International Journal of Rheumatic Diseases, vol.44, issue.3, pp.240-245, 2010.
DOI : 10.1111/j.1756-185X.2010.01537.x